The Science of Cancer Health Equity for Sexual and Gender Minority Communities
The Science of Cancer Health Equity for Sexual and Gender Minority Communities
批准号:
10749970
负责人:
Charles Stewart Kamen
金额:
$3.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-22 至 2024-08-31
关键词:
AddressAmerican Cancer SocietyAreaAttentionAwardAwarenessBackCancer CenterCancer ControlCancer PatientCancer ScienceCancer SurvivorshipCancer health equityCaregiversCollaborationsCommunitiesCommunity ActionsComplexConsensusDataData CollectionDiagnosisDisparityEpidemiologyFeesFundingFutureGender IdentityGeographyHealthIndividualInfrastructureInterventionLesbian Gay Bisexual TransgenderLesbian Gay Bisexual Transgender IntersexLevel of EvidenceLos AngelesMalignant NeoplasmsMedical centerMentorshipMinorityModelingModificationNamesNational Cancer InstituteNational Institute on Minority Health and Health DisparitiesNew YorkNew York CityParticipantPatientsPeer ReviewPersonsPoliciesPopulationPopulations at RiskProfessional OrganizationsPublicationsRecording of previous eventsResearchResearch MethodologyResearch PersonnelResearch PriorityRisk FactorsSafetyScienceScientistScreening for cancerSex OrientationSexual and Gender MinoritiesStructureSurvivorsTechniquesTrainingTravelUnited States National Institutes of HealthUniversitiesWorkanticancer researchcancer diagnosiscancer health disparitycancer preventioncancer riskcommunity engagementcommunity organizationscostdisparity reductionexperiencegender minority communitygender minority groupinnovationinterestintersectionalitylifetime riskmeetingsmemberminority stressnovelnovel strategiesposterssocialsymposiumtransgender
中文摘要
摘要
性和性别少数群体(SGM)经历了与癌症相关的多种差异,包括更高的发病率
癌症风险因素,较低的癌症筛查率,较高的终身癌症风险,以及在
癌症存活期。尽管许多国家组织,包括国家癌症研究所(NCI)和
美国癌症协会(ACS)表示,需要在SGM社区中进行更多的癌症研究,
目前,对于最高的研究优先顺序、有前途的研究模式或机制还没有达成共识
用于地理上分散的科学团队之间的协作。为了解决这一差距,我们提出了一项2和-
为期半天的会议聚焦于“SGM社区癌症健康公平的科学”。这
会议将把研究人员、学员、早期调查人员和社区利益相关者聚集在一起
回顾当前关于SGM人群癌症健康公平性的科学,确定高优先级的研究主题,以及
开发新的方法来吸引社区并影响政策。会议将在纽约新机场举行。
纽约大学朗格尼医学中心校区于2023年10月5日至7日在纽约市举行。它是结构化的
围绕跨学科框架:在科学专门知识和
以社区智慧确定优先事项。根据这一框架,我们召集了一次会议组织
由两名MPI、来自7个癌症中心的代表和一个SGM社区行动委员会组成的委员会,
在SGM社区组织的大力支持下,如全国LGBT癌症网络。
需要NCI R13机制(PA-21-151)的支持,以支付演讲者费用和旅费
适用于受训人员、早期调查人员、患者和社区参与者。这次会议的目的是
1)检查当前水平的证据,为整个癌症控制连续体的研究提供信息
SGM癌症患者、幸存者和照顾者;2)建立未来癌症研究的重点
SGM癌症患者、幸存者和照顾者的控制连续体;3)促进学员的研究
和早期调查人员,特别是那些来自小规模背景的调查人员,对各地的研究感兴趣
SGM社区的癌症控制连续体;4)发展一个跨学科的学者网络
重点放在指导和共享研究方法上,以解决整个国家的癌症健康公平问题
癌症控制连续体;5)传播本次会议的成果,包括未来SGM的优先事项
癌症健康公平研究,通过公开的执行摘要和同行评议的开放的
Access出版物。如果得到资助,这次会议将产生:(A)一份公布的SGM癌症健康公平清单
研究优先事项和(B)跨学科研究人员和社区成员网络
在解决这些优先事项的项目上进行协作。此R13奖项还将帮助我们创建基础架构
未来的会议将继续这项工作,下届会议将于2024年在洛杉矶由锡达斯·西奈主办。
英文摘要
ABSTRACT
Sexual and gender minority people (SGM) experience multiple cancer-related disparities, including higher rates
of cancer risk factors, lower rates of cancer screening, higher lifetime risk of cancer, and unmet needs during
cancer survivorship. Although many national organizations, including the National Cancer Institute (NCI) and the
American Cancer Society (ACS), have stated the need for more cancer research among SGM communities,
there is currently no consensus about the highest research priorities, promising research models, or mechanisms
for collaboration between geographically dispersed scientific teams. To address this gap, we propose a two-and-
a-half day conference focused on the “Science of Cancer Health Equity for SGM Communities.” This
conference will bring together researchers, trainees, early-stage investigators, and community stakeholders to
review the current science on cancer health equity for SGM persons, identify high-priority research topics, and
develop novel approaches to engage communities and influence policy. The conference will be held at the New
York University (NYU) Langone Medical Center Campus in New York City from October 5-7, 2023. It is structured
around a transdisciplinary framework: looking within, across, and between areas of scientific expertise and
community wisdom to establish priorities. In line with this framework, we have convened a conference organizing
committee comprising two MPIs, representatives from 7 cancer centers, and a SGM Community Action Board,
with strong support from SGM community organizations such as the National LGBT Cancer Network.
Support from the NCI R13 mechanism (PA-21-151) is needed to cover speaker fees as well as travel costs
for trainees, early-stage investigators, patients and community participants. The aims of this conference
are: 1) to examine the current level of evidence informing research across the cancer control continuum for
SGM cancer patients, survivors, and caregivers; 2) to establish future research priorities across the cancer
control continuum for SGM cancer patients, survivors, and caregivers; 3) to promote the research of trainees
and early stage investigators, especially those from minoritized backgrounds, interested in research across
the cancer control continuum for SGM communities; 4) to develop a transdisciplinary network of scholars
with a focus on mentorship and on shared research methods that can address cancer health equity across the
cancer control continuum; 5) to disseminate findings from this conference, including priorities for future SGM
cancer health equity research, through a publicly available executive summary and a peer-reviewed, open
access publication. If funded, this conference will produce: (a) a publicized list of SGM cancer health equity
research priorities and (b) a network of transdisciplinary researchers and community members ready to
collaborate on projects addressing these priorities. This R13 award will also help us create an infrastructure
for future conferences to continue this work, with the next hosted by Cedars Sinai in Los Angeles in 2024.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
-
批准号:10714336
-
项目类别:
-
资助金额:$81.59万
-
财政年份:2023
-
负责人:Charles Stewart Kamen
-
依托单位:
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
-
批准号:10220449
-
项目类别:
-
资助金额:$105.99万
-
财政年份:2021
-
负责人:Charles Stewart Kamen
-
依托单位:
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
-
批准号:10883853
-
项目类别:
-
资助金额:$249.49万
-
财政年份:2021
-
负责人:Charles Stewart Kamen
-
依托单位:
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
-
批准号:10391553
-
项目类别:
-
资助金额:$100.42万
-
财政年份:2021
-
负责人:Charles Stewart Kamen
-
依托单位:
Exercise Intervention for Lesbian, Gay, Bisexual, and Transgender Cancer Survivors
-
批准号:9512855
-
项目类别:
-
资助金额:$16.61万
-
财政年份:2015
-
负责人:Charles Stewart Kamen
-
依托单位:
Exercise Intervention for Lesbian, Gay, Bisexual, and Transgender Cancer Survivors
-
批准号:9112953
-
项目类别:
-
资助金额:$16.61万
-
财政年份:2015
-
负责人:Charles Stewart Kamen
-
依托单位:
海外基金